Q4 2025 Definitive Healthcare Corp Earnings Call Transcript
Key Points
- Definitive Healthcare Corp (DH) outperformed its revenue expectations for both subscription and professional services, with total revenue reaching $61.5 million.
- Adjusted EBITDA was $18.1 million, representing a margin of 29%, which was above the high end of guidance.
- The company generated approximately $55 million of unlevered free cash flow over the trailing 12 months.
- Significant progress was made in data differentiation, including the release of a new claims data source, restoring claims data volumes to above historical levels.
- The company successfully deepened integrations with platforms like Snowflake, Databricks, and HubSpot, improving customer satisfaction and retention.
- Total revenue declined by 1% year over year, and subscription revenues declined by 3%.
- Net dollar retention declined due to ongoing pressure on upsell opportunities.
- The company faced top-line pressures and a dynamic macro environment, impacting revenue growth.
- There was a significant disruption in the claims data market, which impacted customer retention and satisfaction.
- Guidance for 2026 indicates a revenue decline of 6 to 9% year over year, reflecting ongoing challenges.
Good afternoon. Thank you for joining us today to review Definitive Healthcare's financial results. Joining me on the call today are Kevin Koop, Chief Executive Officer, and Casey Heller, Chief Financial Officer.
During this call we will make forward-looking statements including but not limited to statements related to our market and future performance and growth opportunities, the benefits of our differentiated data and healthcare commercial intelligence solutions, our competitive position, customer behaviors, and use of our solution.
Customer growth, renewals and retention, our financial guidance, our planned investments and operational strategy generating value for our customers and shareholders, and the anticipated impacts of global macroeconomic conditions on our business results in customers and on the healthcare industry generally.
Any forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1,995.
Forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
